Showing results (541-550 of 562) with videos related to

Sort By:
Pageof 57
Stem Cells (Dayton, Ohio)|February 21, 2019
Coordinating Tissue Regeneration Through Transforming Growth Factor-β Activated Kinase 1 Inactivation and ReactivationHsiao Hsin Sung Hsieh, Shailesh Agarwal, David J Cholok, et al.
BMJ Open|May 19, 2022
Guidance relevant to the reporting of health equity in observational research: a scoping review protocolAnita Rizvi, Daeria O Lawson, Taryn Young, et al.
Diabetes|June 23, 2009
Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variantsTamara J Nicolson, Elisa A Bellomo, Nadeeja Wijesekara, et al.
BMJ Open|March 12, 2024
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventionsJack Wilkinson, Calvin Heal, George A Antoniou, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventionsJack Wilkinson, Calvin Heal, George A Antoniou, et al.
BMJ (Clinical Research Ed.)|April 14, 2025
CONSORT 2025 statement: updated guideline for reporting randomised trialsSally Hopewell, An-Wen Chan, Gary S Collins, et al.
Nature Medicine|April 14, 2025
CONSORT 2025 statement: updated guideline for reporting randomized trialsSally Hopewell, An-Wen Chan, Gary S Collins, et al.
BMC Medicine|August 1, 2025
Reporting guideline for Chatbot Health Advice studies: the CHART statementBright Huo, Gary Collins, David Chartash, et al.
JAMA|April 14, 2025
CONSORT 2025 Statement: Updated Guideline for Reporting Randomized TrialsSally Hopewell, An-Wen Chan, Gary S Collins, et al.
Lancet (London, England)|April 17, 2025
CONSORT 2025 statement: updated guideline for reporting randomised trialsSally Hopewell, An-Wen Chan, Gary S Collins, et al.
Pageof 57